Healthequity Inc
F:2HE
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Intrinsic Value
The intrinsic value of 
Healthequity Inc (2HE) under the Base Case is 84.58 EUR per share.
Compared with the current market price of 92.5 EUR, the stock appears
Overvalued by 9% .
The intrinsic value is the average of valuations using the DCF method and multiples.
Do our valuations actually work? See backtest results .
Cheap or expensive for this stock?
This block shows whether today’s valuation is cheap or expensive compared with the stock’s own history, and what happened after similar valuations in the past.
We compare the gap between the stock’s price and our estimated value over time.
- Undervalued can still be historically expensive. The stock may trade below our estimated value, but usually offer an even bigger discount.
- Overvalued can still be historically cheap. The stock may trade above our estimated value, but usually carry an even higher premium.
Market expectations can differ from our model, which may not fully capture everything affecting the price. That is why some stocks regularly trade above our estimated value and others below it.
The scale and chart show how today’s valuation compares with the past. The cards summarize past returns and waiting times until the stock stopped being cheap or expensive. This can happen because the price changed, our estimated value changed, or both.
Only completed periods are included. These are past results, not forecasts. The usual historical range does not necessarily mean fair value.
Fundamental Analysis
What Healthequity Does
Healthequity helps employers and their workers manage health savings accounts and other tax-advantaged healthcare spending accounts. It provides the account administration, recordkeeping, debit cards, online tools, and payment processing that let people save for medical expenses and pay eligible bills. It also offers ways to invest balances once they grow large enough, usually through partner investment platforms.
- Headquarters
- United States of America US
- Employees
- 2 814
- IPO date
- Jul 31, 2014
Healthequity has no economic moat
Healthequity Inc lacks an economic moat, leaving it vulnerable to competitive pressures and market challenges.
Read the full moat analysis
Revenue & Expenses Breakdown
Healthequity Inc
Earnings Waterfall
Healthequity Inc
What is the Intrinsic Value of one 2HE stock?
The intrinsic value for Healthequity Inc (2HE) under the Base Case is 84.58 EUR.
Is 2HE stock undervalued or overvalued?
Compared with the current market price of 92.5 EUR, the stock appears Overvalued by 9% .
